Candriam SCA’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-36,683
| Closed | -$2.02M | – | 910 |
|
|
2022
Q2 | $2.02M | Buy |
+36,683
| New | +$2.02M | 0.02% | 507 |
|
|
2019
Q2 | – | Sell |
-18,000
| Closed | -$1.23M | – | 846 |
|
|
2019
Q1 | $1.23M | Hold |
18,000
| – | – | 0.02% | 589 |
|
|
2018
Q4 | $950K | Hold |
18,000
| – | – | 0.01% | 590 |
|
|
2018
Q3 | $1.22M | Hold |
18,000
| – | – | 0.02% | 586 |
|
|
2018
Q2 | $2.13M | Hold |
18,000
| – | – | 0.03% | 471 |
|
|
2018
Q1 | $1.49M | Buy |
18,000
+3,000
| +20% | +$248K | 0.03% | 530 |
|
|
2017
Q4 | $2.24M | Buy |
+15,000
| New | +$2.24M | 0.04% | 429 |
|
|
2016
Q1 | – | Sell |
-1,780
| Closed | -$1.07M | – | 658 |
|
|
2015
Q4 | $1.07M | Hold |
1,780
| – | – | 0.03% | 379 |
|
|
2015
Q3 | $1.46M | Buy |
+1,780
| New | +$1.46M | 0.04% | 385 |
|